Our CRISPR screen identified key components of the Hippo pathway in hepatoblastoma (Fig. 6f), including the oncogenic transcription factor YAP and its interaction partner TAZ, both of which are required for cancer cell survival. Here, YAP1 is linked to hepatoblastoma.